NAD+ vs NADH: The Difference in Cells and Supplements

NAD+ and NADH are two forms of the same coenzyme: NAD+ is oxidized, while NADH carries electrons in its reduced form. Cells cycle between them during metabolism. That relationship does not mean an NADH tablet and an NAD+ injection have the same effects or supporting research ¹.

If you are comparing products for fatigue, the important distinction is what researchers actually tested. NADH has small clinical studies of its own; much of the broader NAD+ marketplace points instead to NR or NMN studies.

Featured partner

CoreAge Rx

From $93/mo

Check availabilityRead our review

Affiliate link. We may earn a commission at no extra cost to you.

Affiliate partner

Embody

NAD+ injection or nasal spray, dosing protocol published

See Embody↗

Brain-energy research also appears in NAD+ and bipolar disorder claims. A brain metabolite change or a study conducted at a bipolar center does not by itself establish a treatment for bipolar disorder.

The chemistry without the sales pitch

NAD+ accepts electrons during metabolic reactions and becomes NADH. NADH can then pass electrons along pathways used in energy production. Both forms have a job; “reduced” is a chemical description, not a quality rating ¹.

Nor does “more NADH” automatically mean more usable energy. Cellular compartments, recycling and the balance between forms matter. A supplement label cannot tell you that your cells need more of one side of the pair. Our NAD+ basics explains the larger picture.

What do NADH fatigue studies show?

A 1999 randomized crossover pilot involved 26 people with chronic fatigue syndrome. Favorable responses were reported in 8 participants on NADH versus 2 on placebo. The study was small and short, and the authors called for further trials ². It supports a research question, not a reliable prediction of benefit for everyday tiredness.

A later trial studied a combination of CoQ10 and NADH in people with ME/CFS ³. A combination study cannot isolate NADH's contribution. Disease-specific participants and questionnaire outcomes also limit what can be concluded for healthy adults shopping for more energy.

Our ME/CFS evidence review covers this distinction in context. Persistent fatigue deserves clinical assessment; it should not be assumed to be a deficiency of either NAD form.

Does NAD+ have stronger evidence?

That depends on the product and goal. The most common leap is to use an oral precursor trial to advertise injected NAD+. They are different interventions. For the broader question, see NAD+ therapy evidence; for swallowed products, NR versus NMN is the more relevant comparison.

A study that raises a biomarker is useful, but it cannot establish symptom relief by itself. Look for the actual outcome, study population, treatment duration and comparator. A claim that “NAD is proven” is too broad to guide a purchase.

What about NAD+ for ADHD?

The cited ADHD research does not establish NAD+, NADH, NR or NMN as an ADHD treatment. A 2025 study compared gut microbes and fecal metabolites in people with and without ADHD, and also transferred gut flora into rats. It reported differences involving nicotinamide-related metabolism ⁴. It did not test whether giving an NAD product improves attention, impulsivity or daily functioning.

Nicotinamide is also a different substance from NADH or an NAD+ injection. A metabolic association can suggest a research question; it cannot identify a supplement dose or show that correcting a laboratory result improves ADHD symptoms. Results in rat behavior do not answer that clinical question either. ADHD and autism are distinct diagnoses, so evidence for one should not be substituted for the other.

What does the autism NADH pilot actually show?

The original report of a small 2011 pilot compared oral NADH with ribose in autistic children over a short period and focused on biochemical markers. It was not a placebo-controlled symptom-efficacy trial, and its authors reported no consistent behavioral or functional improvement ⁵.

That is preliminary biochemical research, not evidence that NADH treats autism or that commercial NAD+ injections improve autistic people's wellbeing. It also cannot establish long-term pediatric safety. The paper's NADH intervention was not NAD+, NR or NMN; swapping those names would change the study. Questions about a child's supplements belong with their treating clinician, alongside the child's own needs and goals.

Choosing between products

Start with the ingredient name, not the largest word on the front of the package. Determine whether the product contains NADH, NAD+, NR or NMN, and whether the cited study used the same ingredient and route. Then decide whether the measured outcome is relevant to you.

Do not treat stacking NAD+ and NADH as a way to cover both sides of metabolism. Clinical evidence has not established a universal combination regimen for energy or healthy aging. The energy guide is a better starting point than a theory about balancing supplements.

If comparing by price, use the total cost per month and the actual formulation rather than milligrams alone. Equal ingredient weights across different compounds do not establish equal biological or clinical effects.

What the larger combination trial can and cannot show

The 2021 ME/CFS trial enrolled 207 participants and studied daily oral CoQ10 plus NADH over a 12-week study period. It used patient-reported fatigue, sleep and quality-of-life measures ³. The ingredient amounts were 200 mg CoQ10 and 20 mg NADH daily; those are study details, not a suggested regimen.

There are two important reading traps. First, improvement within a treated group over time is not the same finding as a clear treatment advantage over placebo for every outcome. Second, a two-ingredient trial cannot tell you what NADH alone contributed. The study authors called for confirmation, which is a more careful position than marketing the combination as a settled treatment.

The earlier NADH-only pilot was much smaller, involved short treatment periods and studied a defined illness ². Reading the two together provides context for further investigation. It does not justify extending their findings to jet lag, ordinary post-work tiredness or healthy aging.

Why the NAD+/NADH ratio is not a shopping target

A product may advertise “redox balance” without specifying a validated test or an outcome that its use improves. Cellular chemistry is dynamic and occurs in different compartments. A single consumer measurement should not be assumed to tell you which supplement to buy or how much to take.

Ask what the test measures, what population established its range and what evidence links changing the result to the benefit you want. If the answer is another explanation of how cells work, the clinical question remains open.

A fair side-by-side purchase comparison

Write down the exact ingredient, route, study cited and intended outcome for each product. If one seller cites ME/CFS research and another cites an NR biomarker study, there is no head-to-head evidence in that comparison. A price difference cannot establish which is more effective.

For a person with ongoing fatigue, the most useful first decision may be clinical assessment rather than choosing between two coenzyme labels. For someone already considering a supplement, a clearly stated uncertainty is more informative than a promise to optimize both sides of metabolism.